Icosagen is a private, independent family-business, advancing therapeutic proteins from mammalian cells since 26 years. As CRDMO, we uniquely combine pre-clinical CRO & clinical CDMO capabilities at one site, advancing molecules from discovery through R&D stages, into stable IcoCell® CHO cell lines & GMP manufacturing. From mAbs, complex multi-specifics to ADCs or recombinant proteins, We accelerate the programs of over 100 biotechs annually, eliminating error-prone tech transfers to save our partners’ time, cost & effort. Icosagen’s unique business model has enabled the sustainable establishment of drug development initiatives using the established proprietary technologies. Recent patent applications extend to novel drug candidates, including neutralizing and inhibiting antibodies targeting cancer, chronic pain and infectious disease. Icosagen also leads a consortium implementing CAR-T cell therapy in Estonia. | Mammalian Protein Contract Research, Development & Manufacturing Organization (CRDMO). Uniquely combining CRO & CDMO capabilities to discover, develop & manufacture protein drug candidates, from research to pre-clinical to clinical development stages. | With over 25 years of experience, we uniquely combine pre-clinical CRO and clinical CDMO capabilities under one roof. We discover, develop and manufacture protein drug candidates from research concepts up to clinical GMP manufacturing. In 2024 we worked together with over 100 pharmaceutical companies, successfully completing over 450 projects, and producing over 2100 different proteins. Clients come back to us, because of our devotion to meet their satisfaction with our high-quality services and fast communication. They trust us for custom-tailored solutions in every stage of drug development.
Houston Omics Collaborative
Houston Omics Collaborative (HOC) is an academic proteomic biomarkers & autoantibody service facility at the University of Houston. Based on a Non-Profit Model, HOC offers academic researchers services for identifying proteomic and autoantibody biomarkers, using platforms such as SomaLogic SomaScan, Olink, planar arrays, Mesoscale, and various autoantibody screens.
GenuIN Biotechnologies
GenuIN is a new biotech company in Rockville, MD that provides high-specificity research antibodies validated through gene knockdown. Our standard is: an antibody is high quality if there is a significant reduction or complete loss of signal following target knockdown. Our high throughput knockdown-validation platform is capable of performing up to 500 knockdowns/week, which allows us to generate not only a catalog of validated antibodies, but also shRNA knockdown-related reagents such as lentiviral particles, stable cell lines, cell lysates, and more. Both antibodies and knockdown reagents are validated within the same system, ensuring reliable and reproducible results. For services, GenuIN offers custom antibody development and stable knockdown cell line generation. Our goal is to provide you with REAL reagents that truly work, so you can raise the bar in your research. Come by our booth 3038 to ask about free samples of our antibodies and our unique lysis buffer that doesn’t require inhibitors and can extract large and PTM proteins.
GenScript USA Inc
GenScript USA Inc is a pioneering biotechnology company dedicated to advancing life science research, drug discovery, and development through innovative solutions. With a relentless commitment to excellence, GenScript has become a global leader in providing a comprehensive portfolio of services and products that empower scientists and researchers to push the boundaries of science and medicine. Our expertise spans a wide spectrum of disciplines, including gene synthesis, IVT mRNA, peptides, gene editing, protein engineering, antibody development, cell line generation, and molecular biology reagents. We pride ourselves on our ability to accelerate research and development timelines by delivering high-quality, reliable tools and services that fuel breakthroughs in various scientific fields. Learn more about us at www.genscript.com | GenScript USA Inc is the world’s leading technology and service provider of life science R&D and manufacturing. Built upon solid gene synthesis technology, GenScript offers comprehensive services supporting gene and cell therapy development. From Gene Synthesis, CRISPR sgRNA, Non-viral Payload (ssDNA, dsDNA), mRNA, Oligo, Peptide synthesis, to protein, antibody and virus production. GenScript also offers CDMO platforms supporting GCT with cGMP CRISPR sgRNA/NVPs, plasmids, and virus. We are dedicated to providing reliable, high-quality, and innovative reagents and instruments with superior customer service to enable success across a wide variety of existing and emerging life science research and development areas. We will help you Make Research Easy.
GeneTex
GeneTex is proud to offer the highest quality antibody reagents supported by extensive research, development, and validation. We are committed to the highest standards of product performance.
GeneCopoeia
GeneCopoeia has manufactured and released into the market the largest number of human full length protein coding ORF cDNA clones in multiple sets of vector systems with various features which make these clones suitable for a variety of functional assays, protein expression and easy purification in many cell types as well as cell free transcription and translation coupling systems, and large-scale functional genomics and proteomics studies.
FUJIFILM Wako Pure Chemical Corporation
FUJIFILM Group (Wako and Irvine Scientific) is the exclusive provider of JCRB cell lines. JCRB (Japanese Collection of Research Bioresources) is one of the most comprehensive cell banks, offering a wide variety of cell lines to researchers worldwide for basic and applied science across many fields of research. FUJIFILM also provides high-quality CRO services and custom antibody manufacturing service. Additionally, FUJIFILM Wako offers the F-PODⓇ (Fukushima Patient-Derived Tumor Organoid) and facilitates the use of biospecimens from Okayama University Hospital Biobank. We supply a wide array of chemical reagents and life science reagents for testing and research purposes.
Frontage Laboratories, Inc.
Frontage Laboratories, Inc., is a global Contract Research Organization (CRO) which provides integrated, science-driven, product development services from drug discovery to late phase clinical process to enable biopharmaceutical companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Frontage has enabled many biotechnology companies and leading pharmaceutical companies of varying sizes to advance a myriad of new molecules through development and to successfully file global regulatory submissions. | We are a CRO providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. We have enabled many innovator, generic and consumer health companies of all sizes to file IND, NDA, ANDA, BLA and 505(b)(2) submissions in global markets allowing for successful development of important therapies and products for patients. We are committed to providing rigorous scientific expertise to ensure the highest quality and compliance. We have successfully assisted clients to advance hundreds of molecules through development to commercial launch in global markets.
FluoroFinder
FluoroFinder simplifies and accelerates fluorescence-based experiment design through online tools that reduce errors, save time, and integrate data from a large catalogue of reagents and instruments to provide an end-to-end workflow, supported by rich educational resources to guide researchers. Illuminate your fluorescence driven research on one optimized platform – plan, educate, collaborate, and innovate.